.

Deeper Knowledge, Faster

  • Plan your formulary budget
  • Predict branded drug patent expiration
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Johnson and Johnson
Queensland Health
Mallinckrodt
McKesson
Covington
Deloitte
Julphar
Harvard Business School
Cipla
Boehringer Ingelheim

Generated: June 25, 2017

DrugPatentWatch Database Preview

Benztropine mesylate - Generic Drug Details

« Back to Dashboard

What are the generic sources for benztropine mesylate and what is the scope of benztropine mesylate patent protection?

Benztropine mesylate
is the generic ingredient in two branded drugs marketed by Upsher-smith Labs, Oxford Pharms, Quantum Pharmics, Usl Pharma, Aspen Global Inc, Oak Pharms Akorn, Vintage, Navinta Llc, Fresenius Kabi Usa, Luitpold, Pliva, Epic Pharma Llc, Frontida Biopharm, Leading Pharma Llc, Lannett Holdings Inc, Hikma Farmaceutica, Merck, and Invagen Pharms, and is included in twenty-nine NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

There are five drug master file entries for benztropine mesylate. Thirty-five suppliers are listed for this compound.

Summary for Generic Name: benztropine mesylate

Tradenames:2
Patents:1
Applicants:18
NDAs:29
Drug Master File Entries: see list5
Suppliers / Packagers: see list35
Bulk Api Vendors: see list62
Clinical Trials: see list529
Therapeutic Class:Antiparkinson Agents
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:benztropine mesylate at DailyMed

Pharmacology for Ingredient: benztropine mesylate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Oak Pharms Akorn
COGENTIN
benztropine mesylate
INJECTABLE;INJECTION012015-001Approved Prior to Jan 1, 1982APRXYesYes► Subscribe► Subscribe
Invagen Pharms
BENZTROPINE MESYLATE
benztropine mesylate
TABLET;ORAL090294-002Mar 29, 2010AARXNoNo► Subscribe► Subscribe
Vintage
BENZTROPINE MESYLATE
benztropine mesylate
TABLET;ORAL040715-002Aug 27, 2007AARXNoNo► Subscribe► Subscribe
Pliva
BENZTROPINE MESYLATE
benztropine mesylate
TABLET;ORAL089058-001Aug 10, 1988AARXNoNo► Subscribe► Subscribe
Merck
COGENTIN
benztropine mesylate
TABLET;ORAL009193-003Approved Prior to Jan 1, 1982DISCNYesNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Farmers Insurance
Harvard Business School
Healthtrust
Novartis
Cerilliant
Cipla
Queensland Health
Colorcon
Chubb
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot